Company
Headquarters: Harbin, China
Employees: 1,432
CN¥9.33 Billion
CNY as of Jan. 1, 2026
US$1.33 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| AstraZeneca | $284.38 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Aurora Optoelectronics Co.,Ltd. researches, develops, produces, prepares, and sells sapphire crystal materials and equipment in China. It also offers material processing, polishing, flat grinding, edge grinding, milling, and engraving machines, as well as 3D glass hot bending machine. The company was founded in 2006 and is based in Harbin, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥422.8 M |
| EBITDA | CN¥105.2 M |
| Gross Profit TTM | CN¥45.4 M |
| Profit Margin | 34.76% |
| Operating Margin | 7.79% |
| Quarterly Revenue Growth | 40.00% |
Aurora Optoelectronics Co.,Ltd. has the following listings and related stock indices.
Stock: SSE: 600666